Literature DB >> 1819481

The Myc:Max protein complex and cell growth regulation.

E M Blackwood1, B Lüscher, L Kretzner, R N Eisenman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1819481     DOI: 10.1101/sqb.1991.056.01.015

Source DB:  PubMed          Journal:  Cold Spring Harb Symp Quant Biol        ISSN: 0091-7451


× No keyword cloud information.
  15 in total

1.  Identification of a rel-related protein in the nucleus during the S phase of the cell cycle.

Authors:  R B Evans; P D Gottlieb; H R Bose
Journal:  Mol Cell Biol       Date:  1993-10       Impact factor: 4.272

2.  Mutation and association analyses of the candidate genes ESR1, ESR2, MAX, PCNA, and KAT2A in patients with unexplained MSH2-deficient tumors.

Authors:  Nils Rahner; Felix F Brockschmidt; Verena Steinke; Philip Kahl; Tim Becker; Hans F A Vasen; Juul T Wijnen; Carli J M Tops; Elke Holinski-Feder; Marjolijn J L Ligtenberg; Liesbeth Spruijt; Heike Görgens; Susanne Stemmler; Matthias Kloor; Wolfgang Dietmaier; Johannes Schumacher; Markus M Nöthen; Peter Propping
Journal:  Fam Cancer       Date:  2012-03       Impact factor: 2.375

3.  Overexpression of c-Myc alters G(1)/S arrest following ionizing radiation.

Authors:  Joon-Ho Sheen; Robert B Dickson
Journal:  Mol Cell Biol       Date:  2002-03       Impact factor: 4.272

4.  Myc and Max: molecular evolution of a family of proto-oncogene products and their dimerization partner.

Authors:  W R Atchley; W M Fitch
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

5.  The myc intron-binding polypeptide associates with RFX1 in vivo and binds to the major histocompatibility complex class II promoter region, to the hepatitis B virus enhancer, and to regulatory regions of several distinct viral genes.

Authors:  W Reinhold; L Emens; A Itkes; M Blake; I Ichinose; M Zajac-Kaye
Journal:  Mol Cell Biol       Date:  1995-06       Impact factor: 4.272

Review 6.  Pheochromocytomas and Paragangliomas: Clinical and Genetic Approaches.

Authors:  Marcia Helena Soares Costa; Tania M Ortiga-Carvalho; Alice Dutra Violante; Mario Vaisman
Journal:  Front Endocrinol (Lausanne)       Date:  2015-08-17       Impact factor: 5.555

7.  Functional promoter polymorphisms govern differential expression of HMG-CoA reductase gene in mouse models of essential hypertension.

Authors:  Parshuram J Sonawane; Bhavani S Sahu; Binu K Sasi; Parimala Geedi; Govinda Lenka; Nitish R Mahapatra
Journal:  PLoS One       Date:  2011-01-31       Impact factor: 3.240

8.  Global identification of Myc target genes reveals its direct role in mitochondrial biogenesis and its E-box usage in vivo.

Authors:  Jonghwan Kim; Ji-hoon Lee; Vishwanath R Iyer
Journal:  PLoS One       Date:  2008-03-12       Impact factor: 3.240

9.  Early Transcriptomic Response to LDL and oxLDL in Human Vascular Smooth Muscle Cells.

Authors:  Salvador Damián-Zamacona; Paola Toledo-Ibelles; Mabel Z Ibarra-Abundis; Laura Uribe-Figueroa; Enrique Hernández-Lemus; Karla Paola Macedo-Alcibia; Blanca Delgado-Coello; Jaime Mas-Oliva; Juan Pablo Reyes-Grajeda
Journal:  PLoS One       Date:  2016-10-11       Impact factor: 3.240

10.  AP-2alpha Inhibits c-MYC Induced Oxidative Stress and Apoptosis in HaCaT Human Keratinocytes.

Authors:  Lei Yu; Michael J Hitchler; Wenqing Sun; Ehab H Sarsour; Prabhat C Goswami; Aloysius J Klingelhutz; Frederick E Domann
Journal:  J Oncol       Date:  2009-12-24       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.